Search For "antibody"
DST funded start-up's ELISA test to better estimate COVID 19 antibody conc
Updated : 4 years, 9 months ago IST
New Delhi [India], May 22 (ANI): A Department of Science and Technology (DST) supported technology-- Electrochemical ELISA test -- enables fast and accurate estimation of antibody concentration of COVID-19 in clinical samples, Ministry of Science and Technology said on Saturday.
Read More
DRDO develops antibody test kit DIPCOVAN for early detection of COVID-19
Updated : 4 years, 9 months ago IST
New Delhi [India], May 21 (ANI): The Defence Research and Development Organisation (DRDO) has developed an antibody test kit for the early screening of COVID.
Read More
Structural details of how SARS-CoV-2 variants escape immune response revea
Updated : 4 years, 9 months ago IST
California [US], May 21 (ANI): Fast-spreading variants of the COVID-19-causing coronavirus, SARS-CoV-2, carry mutations that enable the virus to escape some of the immune response created naturally or by vaccination. A new study by a team of researchers has revealed key details of how these
Read More
Newly identified antibody can be targeted by HIV vaccines: Study
Updated : 4 years, 9 months ago IST
Washington [US], May 20 (ANI): A newly-identified group of antibodies that binds to a coating of sugars on the outer shell of HIV is effective in neutralizing the virus and points to a novel vaccine approach that could also potentially be used against SARS-CoV-2 and fungal pathogens, researc
Read More
Global sales of Celltrion's COVID-19 antibody-drug Regkirona begin
Updated : 4 years, 10 months ago IST
Seoul [South Korea], May 12 (ANI/Global Economic): Worldwide sales of Regkirona (active ingredient: regdanvimab), a COVID-19 antibody drug developed by South Korean biopharmaceutical company Celltrion Inc, has begun.
Read More
Switch of breast tumors to HER2-low might provide greater therapeutic opti
Updated : 4 years, 10 months ago IST
Lugano [Switzerland], May 9 (ANI): The finding that breast tumours can evolve to express low HER2 potentially widens the number of patients who can benefit from new investigational agents, typically novel antibody-drug conjugate therapies, that are currently in clinical trials for HER2-low t
Read More
Study uses nanobodies to block tick-borne bacterial infection
Updated : 4 years, 10 months ago IST
Washington [US], April 28 (ANI): The findings of recent research suggest that tiny molecules called nanobodies, which can be designed to mimic antibody structures and functions, might be the key to blocking a tick-borne bacterial infection that remains out of reach of almost all antibiotics.
Read More
Choosing the "Right" test is critical to understand the immune response to
Updated : 4 years, 10 months ago IST
Mumbai (Maharashtra) [India], April 19 (ANI/NewsVoir): Roche Diagnostics India launched its Quantitative antibody test- Elecsys Anti SARS CoV-2 S in January this year. The test since then has now been widely used in government and private hospitals and labs in various parts across the countr
Read More
US revokes authorisation of one of Eli Lilly's COVID-19 monoclonal antibod
Updated : 4 years, 11 months ago IST
Washington [US], April 17 (ANI): The US Food and Drug Administration (FDA) said on Friday that it has revoked it emergency authorisation of Eli Lilly's COVID-19 monoclonal antibody treatment bamlanivimab when used on its own.
Read More
Regeneron antibody cocktail 'helps prevent' symptomatic Covid-19: Drugmake
Updated : 4 years, 11 months ago IST
New York [US], April 13 (ANI): New Phase 3 trial data finds a single shot of Regeneron's Covid-19 antibody cocktail was able to prevent symptomatic Covid-19 among people exposed to the virus, the company said on Monday.
Read More
Study sheds light on reverse-order heart-liver transplant's benefits for c
Updated : 4 years, 11 months ago IST
Minnesota [US], April 2 (ANI): Traditionally, surgeons transplant the heart first followed by the liver. But Mayo Clinic heart transplant team decided to reverse the order for highly sensitised patients in the hopes that the liver would absorb some of the patient's antibodies, removing them
Read More
Regeneron's COVID-19 treatment 'reduces hospitaliations' by 70 pc
Updated : 4 years, 11 months ago IST
New York [US], March 23 (ANI): Regeneron Pharmaceuticals Inc on Tuesday said that its dual antibody treatment for COVID-19 reduced symptomatic illness by four days at any level of dose tried in its clinical trial adding that the treatment also seemed to reduce hospitalizations and death by a
Read More